Effective Combined Medical Treatment With Octreotide Long Acting Release (Sandostatin LAR) and Cabergoline for an Extremely Rare Pituitary Somatotroph Adenoma Producing Growth Hormone-Releasing Hormone-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Effective Combined Medical Treatment With Octreotide Long Acting Release (Sandostatin LAR) and Cabergoline for an Extremely Rare Pituitary Somatotroph Adenoma Producing Growth Hormone-Releasing Hormone

Published:2008-11 Issue:6 Volume:18 Page:266-269
ISSN:1051-2144
Container-title:The Endocrinologist
language:en
Short-container-title:The Endocrinologist

Author:

Matsuno Akira,Katakami Hideki,Okazaki Ryo,Mizutani Akiko,Osamura R Yoshiyuki,Miyawaki Satoru,Uno Takeshi,Ide Fuyuaki,Asano Shuichiro,Tanaka Junichi,Nakaguchi Hiroshi,Sasaki Mitsuyoshi,Murakami Mineko,Yamazaki Kazuto,Ishida Yasuo,Okinaga Hiroko,Teramoto Akira

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Endocrinology, Diabetes and Metabolism

Reference17 articles.

1. P-81 CORRELATION AMONG Ki-67 STAINING INDEX, EXPRESSION OF SOMATOSTATIN RECEPTOR, GROWTH HORMONE DYNAMICS IN GROWTH HORMONE RELEASING HORMONE, BROMOCRIPTIN

2. Effectiveness of adding dopamine agonist therapy to long-acting somatostatin analogues in the management of acromegaly

3. Cabergoline addition to depot somatostatin analogues in resistant acromegalic patients: efficacy and lack of predictive value of prolactin status

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP